| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |